Previous studies had indicated that LRRC4 was down-regulated in glioma biopsies and cell lines [2], [4], and that methylation of the LRRC4 promoter was one of the reasons for LRRC4 inactivation in some gliomas [5]. The gene discussed is LRRC4; the disease is central nervous system cancer.